SIG
BIIB icon

Stonegate Investment Group’s Biogen BIIB Stock Holding History

Stonegate Investment Group’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-1,666
Closed -$323K – 399
2024
Q3 		$323K Sell
1,666
-746
-31% -$156K 0.01% 270
2024
Q2 		$559K Sell
2,412
-129
-5% -$28K 0.02% 214
2024
Q1 		$548K Sell
2,541
-197
-7% -$46.1K 0.02% 209
2023
Q4 		$709K Sell
2,738
-3
-0.1% -$737 0.02% 185
2023
Q3 		$704K Buy
2,741
+115
+4% +$30.8K 0.03% 172
2023
Q2 		$748K Buy
2,626
+50
+2% +$14.9K 0.03% 180
2023
Q1 		$716K Sell
2,576
-26
-1% -$7.19K 0.03% 178
2022
Q4 		$721K Sell
2,602
-155
-6% -$43.8K 0.03% 176
2022
Q3 		$736K Sell
2,757
-72
-3% -$15.3K 0.03% 150
2022
Q2 		$577K Buy
2,829
+5
+0.2% +$1.02K 0.03% 179
2022
Q1 		$595K Sell
2,824
-10
-0.4% -$2.17K 0.02% 161
2021
Q4 		$680K Buy
+2,834
New +$729K 0.03% 153

Other funds holding BIIB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $39.3B AUM 27.96% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Stonegate Investment Group's BIIB Position: Q4 2024 in Review

Stonegate Investment Group sold out of Biogen (BIIB) in Q4 2024, closing a stake of 1,666 shares — an estimated $323K sold.

Stonegate Investment Group first reported a position in BIIB in Q4 2021 and held it in 12 quarters. The position peaked at $748K in Q2 2023. 876 funds tracked by Wall St. Rank hold BIIB as of Q4 2024.

  • Stonegate Investment Group reported no remaining Biogen position as of Q4 2024 after selling out during the quarter.
  • Stonegate Investment Group sold 1,666 Biogen shares in Q4 2024, an estimated $323K.
  • Stonegate Investment Group first reported a position in Biogen in Q4 2021 and held it in 12 quarters.
  • Stonegate Investment Group's Biogen position peaked at $748K in Q2 2023.
  • 876 funds tracked by Wall St. Rank held Biogen as of Q4 2024.

Based on Stonegate Investment Group's 13F filing for Q4 2024, filed 22 Jan 2025.